Newtonian cell interactions shape natural killer cell education

Immunological Reviews

Volumn 267, Issue 1, 2015, Pages 197-213

  Goodridge, Jodie P ^a,b   Önfelt, Björn ^c,d   Malmberg, Karl Johan ^a,b,c  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c KAROLINSKA INSTITUTE   (Sweden)

^d ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

Author keywords

Cell surface molecules; Cytotoxicity; Differentiation; Major histocompatibility complex; Natural killer cells; Repertoire development

Indexed keywords

CD150 ANTIGEN; CYTOKINE RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 15; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TUMOR NECROSIS FACTOR ALPHA; CD226 ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; T LYMPHOCYTE ANTIGEN;

ANTIGEN PRESENTATION; ARTICLE; CELL INTERACTION; CELL STRESS; CELL SURFACE; COPY NUMBER VARIATION; CYTOKINE RELEASE; CYTOKINE RESPONSE; CYTOLYSIS; CYTOTOXICITY; EXOCYTOSIS; HOST CELL; HUMAN; INNATE IMMUNITY; LYMPHOCYTE DIFFERENTIATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MEMORY T LYMPHOCYTE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; STEADY STATE; ANIMAL; BIOLOGICAL MODEL; CELL COMMUNICATION; CELL DIFFERENTIATION; IMMUNOLOGY; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELL COMMUNICATION; CELL DIFFERENTIATION; HUMANS; INTERLEUKIN-15; KILLER CELLS, NATURAL; MODELS, IMMUNOLOGICAL; RECEPTORS, KIR; SIGNAL TRANSDUCTION;

EID: 84939533391     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/imr.12325     Document Type: Article

References (142)

1. Lanier LL. NK cell recognition. Annu Rev Immunol 2005;23:225-274.
2. Bryceson YT, March ME, Ljunggren HG, Long EO. Activation, coactivation, and costimulation of resting human natural killer cells. Immunol Rev 2006;214:73-91.
3. Rahim MM, et al. Ly49 receptors: innate and adaptive immune paradigms. Front Immunol 2014;5:145.
4. Parham P, Norman PJ, Abi-Rached L, Guethlein LA. Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules. Philos Trans R Soc Lond B Biol Sci 2012;367:800-811.
5. Ivarsson MA, Michaelsson J, Fauriat C. Activating killer cell Ig-like receptors in health and disease. Front Immunol 2014;5:184.
6. Uhrberg M. Shaping the human NK cell repertoire: an epigenetic glance at KIR gene regulation. Mol Immunol 2005;42:471-475.
7. Anderson SK. Transcriptional regulation of NK cell receptors. Curr Top Microbiol Immunol 2006;298:59-75.
8. Uhrberg M, et al. Human diversity in killer cell inhibitory receptor genes. Immunity 1997;7:753-763.
9. Andersson S, Malmberg JA, Malmberg KJ. Tolerant and diverse natural killer cell repertoires in the absence of selection. Exp Cell Res 2010;316:1309-1315.
10. Fernandez NC, Treiner E, Vance RE, Jamieson AM, Lemieux S, Raulet DH. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 2005;105:4416-4423.
11. Fauriat C, et al. Estimation of the size of the alloreactive NK cell repertoire: studies in individuals homozygous for the group A KIR haplotype. J Immunol 2008;181:6010-6019.
12. Anfossi N, et al. Human NK cell education by inhibitory receptors for MHC class I. Immunity 2006;25:331-342.
13. Yawata M, Yawata N, Draghi M, Partheniou F, Little AM, Parham P. MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response. Blood 2008;112:2369-2380.
14. Veinotte LL, Wilhelm BT, Mager DL, Takei F. Acquisition of MHC-specific receptors on murine natural killer cells. Crit Rev Immunol 2003;23:251-266.
15. Braud VM, et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998;391:795-799.
16. Andersson S, Fauriat C, Malmberg JA, Ljunggren HG, Malmberg KJ. KIR acquisition probabilities are independent of self-HLA class I ligands and increase with cellular KIR expression. Blood 2009;114:95-104.
17. Raulet DH, Vance RE. Self-tolerance of natural killer cells. Nat Rev Immunol 2006;6:520-531.
18. Sternberg-Simon M, et al. Natural killer cell inhibitory receptor expression in humans and mice: a closer look. Front Immunol 2013;4:65.
19. Held W, Dorfman JR, Wu MF, Raulet DH. Major histocompatibility complex class I-dependent skewing of the natural killer cell Ly49 receptor repertoire. Eur J Immunol 1996;26:2286-2292.
20. Schonberg K, Sribar M, Enczmann J, Fischer JC, Uhrberg M. Analyses of HLA-C-specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition. Blood 2011;117:98-107.
21. Held W, Raulet DH. Ly49A transgenic mice provide evidence for a major histocompatibility complex-dependent education process in natural killer cell development. J Exp Med 1997;185:2079-2088.
22. Beziat V, et al. NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs. Blood 2013;121:2678-2688.
23. Schonberg K, Fischer JC, Kogler G, Uhrberg M. Neonatal NK-cell repertoires are functionally, but not structurally, biased toward recognition of self HLA class I. Blood 2011;117:5152-5156.
24. Brodin P, Lakshmikanth T, Karre K, Hoglund P. Skewing of the NK cell repertoire by MHC class I via quantitatively controlled enrichment and contraction of specific Ly49 subsets. J Immunol 2012;188:2218-2226.
25. Felices M, et al. Functional NK cell repertoires are maintained through IL-2Ralpha and Fas ligand. J Immunol 2014;192:3889-3897.
26. Cooley S, et al. A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immature. Blood 2007;110:578-586.
27. Kim S, et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 2005;436:709-713.
28. Elliott JM, Yokoyama WM. Unifying concepts of MHC-dependent natural killer cell education. Trends Immunol 2011;32:364-372.
29. Hoglund P, Brodin P. Current perspectives of natural killer cell education by MHC class I molecules. Nat Rev Immunol 2010;10:724-734.
30. Brodin P, Karre K, Hoglund P. NK cell education: not an on-off switch but a tunable rheostat. Trends Immunol 2009;30:143-149.
31. Joncker NT, Raulet DH. Regulation of NK cell responsiveness to achieve self-tolerance and maximal responses to diseased target cells. Immunol Rev 2008;224:85-97.
32. Yokoyama WM, Kim S. Licensing of natural killer cells by self-major histocompatibility complex class I. Immunol Rev 2006;214:143-154.
33. Brodin P, Lakshmikanth T, Johansson S, Karre K, Hoglund P. The strength of inhibitory input during education quantitatively tunes the functional responsiveness of individual natural killer cells. Blood 2009;113:2434-2441.
34. Joncker NT, Fernandez NC, Treiner E, Vivier E, Raulet DH. NK cell responsiveness is tuned commensurate with the number of inhibitory receptors for self-MHC class I: the rheostat model. J Immunol 2009;182:4572-4580.
35. + NK cells. J Immunol 2010;184:3424-3432.
36. Kim S, et al. HLA alleles determine differences in human natural killer cell responsiveness and potency. Proc Natl Acad Sci USA 2008;105:3053-3058.
37. Yu J, Heller G, Chewning J, Kim S, Yokoyama WM, Hsu KC. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands. J Immunol 2007;179:5977-5989.
38. Ebihara T, Jonsson AH, Yokoyama WM. Natural killer cell licensing in mice with inducible expression of MHC class I. Proc Natl Acad Sci USA 2013;110:E4232-E4237.
39. Elliott JM, Wahle JA, Yokoyama WM. MHC class I-deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I-sufficient environment. J Exp Med 2010;207:2073-2079.
40. Joncker NT, Shifrin N, Delebecque F, Raulet DH. Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment. J Exp Med 2010;207:2065-2072.
41. Vivier E, et al. Innate or adaptive immunity? The example of natural killer cells. Science 2011;331:44-49.
42. Lucas M, Schachterle W, Oberle K, Aichele P, Diefenbach A. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 2007;26:503-517.
43. Strowig T, et al. Human NK cells of mice with reconstituted human immune system components require preactivation to acquire functional competence. Blood 2010;116:4158-4167.
44. Luetke-Eversloh M, et al. Human cytomegalovirus drives epigenetic imprinting of the IFNG locus in NKG2Chi natural killer cells. PLoS Pathog 2014;10:e1004441.
45. Lee J, et al. Epigenetic modification and antibody-dependent expansion of memory-like NK cells in human cytomegalovirus-infected individuals. Immunity 2015;42:431-442.
46. Schlums H, et al. Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function. Immunity 2015;42:443-456.
47. Germain RN. Maintaining system homeostasis: the third law of Newtonian immunology. Nat Immunol 2012;13:902-906.
48. Pradeu T, Jaeger S, Vivier E. The speed of change: towards a discontinuity theory of immunity? Nat Rev Immunol 2013;13:764-769.
49. Bix M, Liao NS, Zijlstra M, Loring J, Jaenisch R, Raulet D. Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice. Nature 1991;349:329-331.
50. Hoglund P, et al. Recognition of beta 2-microglobulin-negative (beta 2 m-) T-cell blasts by natural killer cells from normal but not from beta 2 m- mice: nonresponsiveness controlled by beta 2 m- bone marrow in chimeric mice. Proc Natl Acad Sci USA 1991;88:10332-10336.
51. Liao NS, Bix M, Zijlstra M, Jaenisch R, Raulet D. MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Science 1991;253:199-202.
52. de la Salle H, et al. Homozygous human TAP peptide transporter mutation in HLA class I deficiency. Science 1994;265:237-241.
53. Hansasuta P, et al. Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific. Eur J Immunol 2004;34:1673-1679.
54. Goodridge JP, Burian A, Lee N, Geraghty DE. HLA-F and MHC class I open conformers are ligands for NK cell Ig-like receptors. J Immunol 2013;191:3553-3562.
55. Beziat V, et al. Influence of KIR gene copy number on natural killer cell education. Blood 2013;121:4703-4707.
56. Johansson S, et al. Natural killer cell education in mice with single or multiple major histocompatibility complex class I molecules. J Exp Med 2005;201:1145-1155.
57. Brodin P, et al. Natural killer cell tolerance persists despite significant reduction of self MHC class I on normal target cells in mice. PLoS ONE 2010;5:e13174. doi: 10.1371/journal.pone.0013174
58. + natural killer cells. Immunogenetics 2012;64:739-745.
59. Fauriat C, Ivarsson MA, Ljunggren HG, Malmberg KJ, Michaelsson J. Education of human natural killer cells by activating killer cell immunoglobulin-like receptors. Blood 2010;115:1166-1174.
60. Pittari G, et al. NK cell tolerance of self-specific activating receptor KIR2DS1 in individuals with cognate HLA-C2 ligand. J Immunol 2013;190:4650-4660.
61. Bjorklund AT, et al. NK cells expressing inhibitory KIR for non-self ligands remain tolerant in HLA-matched sibling stem cell transplantation. Blood 2010;115:2686-2694.
62. Haas P, et al. NK-cell education is shaped by donor HLA genotype after unrelated allogeneic hematopoietic stem cell transplantation. Blood 2011;117:1021-1029.
63. Sungur CM, Tang-Feldman YJ, Zamora AE, Alvarez M, Pomeroy C, Murphy WJ. Murine NK-cell licensing is reflective of donor MHC-I following allogeneic hematopoietic stem cell transplantation in murine cytomegalovirus responses. Blood 2013;122:1518-1521.
64. Bessoles S, Grandclement C, Alari-Pahissa E, Gehrig J, Jeevan-Raj B, Held W. Adaptations of natural killer cells to self-MHC class I. Front Immunol 2014;5:349.
65. Chalifour A, et al. A role for cis interaction between the inhibitory Ly49A receptor and MHC class I for natural killer cell education. Immunity 2009;30:337-347.
66. Johansson MH, Bieberich C, Jay G, Karre K, Hoglund P. Natural killer cell tolerance in mice with mosaic expression of major histocompatibility complex class I transgene. J Exp Med 1997;186:353-364.
67. Smyth MJ, Sullivan LC, Brooks AG, Andrews DM. Non-classical MHC class I molecules regulating natural killer cell function. Oncoimmunology 2013;2:e23336.
68. Patel R, Belanger S, Tai LH, Troke AD, Makrigiannis AP. Effect of Ly49 haplotype variance on NK cell function and education. J Immunol 2010;185:4783-4792.
69. Foley B, et al. NK cell education after allogeneic transplantation: dissociation between recovery of cytokine-producing and cytotoxic functions. Blood 2011;118:2784-2792.
70. Miller JD, Weber DA, Ibegbu C, Pohl J, Altman JD, Jensen PE. Analysis of HLA-E peptide-binding specificity and contact residues in bound peptide required for recognition by CD94/NKG2. J Immunol 2003;171:1369-1375.
71. Merino AM, Sabbaj S, Easlick J, Goepfert P, Kaslow RA, Tang J. Dimorphic HLA-B signal peptides differentially influence HLA-E- and natural killer cell-mediated cytolysis of HIV-1-infected target cells. Clin Exp Immunol 2013;174:414-423.
72. Ivarsson MA, et al. Differentiation and functional regulation of human fetal NK cells. J Clin Invest 2013;123:3889-3901.
73. Guia S, et al. Confinement of activating receptors at the plasma membrane controls natural killer cell tolerance. Sci Signal 2011;4:ra21.
74. Thomas LM, Peterson ME, Long EO. Cutting edge: NK cell licensing modulates adhesion to target cells. J Immunol 2013;191:3981-3985.
75. Jonsson AH, Yokoyama WM. Assessing licensing of NK cells. Methods Mol Biol 2010;612:39-49.
76. Bjorkstrom NK, et al. Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood 2010;116:3853-3864.
77. Enqvist M, et al. Coordinated expression of DNAM-1 and LFA-1 in educated NK cells. J Immunol 2015;194:4518-4527.
78. Voehringer D, Koschella M, Pircher H. Lack of proliferative capacity of human effector and memory T cells expressing killer cell lectinlike receptor G1 (KLRG1). Blood 2002;100:3698-3702.
79. Bryceson YT, March ME, Barber DF, Ljunggren HG, Long EO. Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells. J Exp Med 2005;202:1001-1012.
80. Bottino C, et al. Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J Exp Med 2003;198:557-567.
81. Carlsten M, et al. DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells. Cancer Res 2007;67:1317-1325.
82. Castriconi R, et al. Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-poliovirus receptor interaction. Cancer Res 2004;64:9180-9184.
83. Lakshmikanth T, et al. NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo. J Clin Invest 2009;119:1251-1263.
84. Shibuya K, et al. CD226 (DNAM-1) is involved in lymphocyte function-associated antigen 1 costimulatory signal for naive T cell differentiation and proliferation. J Exp Med 2003;198:1829-1839.
85. Nabekura T, Kanaya M, Shibuya A, Fu G, Gascoigne NR, Lanier LL. Costimulatory molecule DNAM-1 Is essential for optimal differentiation of memory natural killer cells during mouse cytomegalovirus infection. Immunity 2014;40:225-234.
86. Martinet L, et al. DNAM-1 expression marks an alternative program of NK cell maturation. Cell Rep 2015;11:85-97.
87. + blasts in myelodysplastic syndrome. Leukemia 2010;24:1607-1616.
88. Carlsten M, et al. Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells. J Immunol 2009;183:4921-4930.
89. Mamessier E, et al. Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity. J Clin Invest 2011;121:3609-3622.
90. Sanchez-Correa B, et al. Decreased expression of DNAM-1 on NK cells from acute myeloid leukemia patients. Immunol Cell Biol 2012;90:109-115.
91. Shibuya K, et al. Physical and functional association of LFA-1 with DNAM-1 adhesion molecule. Immunity 1999;11:615-623.
92. Liu D, Bryceson YT, Meckel T, Vasiliver-Shamis G, Dustin ML, Long EO. Integrin-dependent organization and bidirectional vesicular traffic at cytotoxic immune synapses. Immunity 2009;31:99-109.
93. Luo BH, Carman CV, Springer TA. Structural basis of integrin regulation and signaling. Annu Rev Immunol 2007;25:619-647.
94. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell 2002;110:673-687.
95. + T cells display immunological synapse defects that impair antitumor immunity. J Immunol 2014;192:553-557.
96. Forslund E, et al. Novel microchip-based tools facilitating live cell imaging and assessment of functional heterogeneity within NK cell populations. Front Immunol 2012;3:300.
97. Vanherberghen B, et al. Classification of human natural killer cells based on migration behavior and cytotoxic response. Blood 2013;121:1326-1334.
98. Becknell B, Caligiuri MA. Interleukin-2, interleukin-15, and their roles in human natural killer cells. Adv Immunol 2005;86:209-239.
99. Huntington ND, et al. IL-15 trans-presentation promotes human NK cell development and differentiation in vivo. J Exp Med 2009;206:25-34.
100. Viant C, Fenis A, Chicanne G, Payrastre B, Ugolini S, Vivier E. SHP-1-mediated inhibitory signals promote responsiveness and anti-tumour functions of natural killer cells. Nat Commun 2014;5:5108.
101. Dunphy SE, et al. 2DL1, 2DL2 and 2DL3 all contribute to KIR phenotype variability on human NK cells. Genes Immun 2015; doi: 10.1038/gene.2015.15. [Epub ahead of print].
102. van Bergen J, et al. HLA reduces killer cell Ig-like receptor expression level and frequency in a humanized mouse model. J Immunol 2013;190:2880-2885.
103. Yawata M, Yawata N, Draghi M, Little AM, Partheniou F, Parham P. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J Exp Med 2006;203:633-645.
104. Zhang Y, et al. In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infection. Immunology 2007;121:258-265.
105. Juelke K, et al. CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells. Blood 2010;116:1299-1307.
106. + NK-cell subset. Blood 2010;116:3865-3874.
107. Horowitz A, et al. Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry. Sci Transl Med 2013;5:208ra145.
108. Beziat V, Descours B, Parizot C, Debre P, Vieillard V. NK cell terminal differentiation: correlated stepwise decrease of NKG2A and acquisition of KIRs. PLoS ONE 2010;5:e11966.
109. Shilling HG, McQueen KL, Cheng NW, Shizuru JA, Negrin RS, Parham P. Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation. Blood 2003;101:3730-3740.
110. Cichocki F, Miller JS, Anderson SK, Bryceson YT. Epigenetic regulation of NK cell differentiation and effector functions. Front Immunol 2013;4:55.
111. Cichocki F, et al. The transcription factor c-Myc enhances KIR gene transcription through direct binding to an upstream distal promoter element. Blood 2009;113:3245-3253.
112. Bjorkstrom NK, et al. CD8 T cells express randomly selected KIRs with distinct specificities compared with NK cells. Blood 2012;120:3455-3465.
113. Santourlidis S, et al. Crucial role of DNA methylation in determination of clonally distributed killer cell Ig-like receptor expression patterns in NK cells. J Immunol 2002;169:4253-4261.
114. Li H, Pascal V, Martin MP, Carrington M, Anderson SK. Genetic control of variegated KIR gene expression: polymorphisms of the bi-directional KIR3DL1 promoter are associated with distinct frequencies of gene expression. PLoS Genet 2008;4:e1000254.
115. Romee R, et al. Cytokine activation induces human memory-like NK cells. Blood 2012;120:4751-4760.
116. Fehniger TA, et al. Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs. Immunity 2007;26:798-811.
117. + natural killer cells with potent function. Blood 2012;119:2665-2674.
118. Della Chiesa M, et al. Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus? Blood 2012;119:399-410.
119. Orr MT, Murphy WJ, Lanier LL. 'Unlicensed' natural killer cells dominate the response to cytomegalovirus infection. Nat Immunol 2010;11:321-327.
120. Bryceson YT, March ME, Ljunggren HG, Long EO. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 2006;107:159-166.
121. Masilamani M, Nguyen C, Kabat J, Borrego F, Coligan JE. CD94/NKG2A inhibits NK cell activation by disrupting the actin network at the immunological synapse. J Immunol 2006;177:3590-3596.
122. Choudhuri K, et al. Polarized release of T-cell-receptor-enriched microvesicles at the immunological synapse. Nature 2014;507:118-123.
123. Orange JS, Harris KE, Andzelm MM, Valter MM, Geha RS, Strominger JL. The mature activating natural killer cell immunologic synapse is formed in distinct stages. Proc Natl Acad Sci USA 2003;100:14151-14156.
124. James AM, et al. Rapid activation receptor- or IL-2-induced lytic granule convergence in human natural killer cells requires Src, but not downstream signaling. Blood 2013;121:2627-2637.
125. Stebbins CC, Watzl C, Billadeau DD, Leibson PJ, Burshtyn DN, Long EO. Vav1 dephosphorylation by the tyrosine phosphatase SHP-1 as a mechanism for inhibition of cellular cytotoxicity. Mol Cell Biol 2003;23:6291-6299.
126. Orange JS, et al. Wiskott-Aldrich syndrome protein is required for NK cell cytotoxicity and colocalizes with actin to NK cell-activating immunologic synapses. Proc Natl Acad Sci USA 2002;99:11351-11356.
127. Carlin LM, Eleme K, McCann FE, Davis DM. Intercellular transfer and supramolecular organization of human leukocyte antigen C at inhibitory natural killer cell immune synapses. J Exp Med 2001;194:1507-1517.
128. Willinger T, Staron M, Ferguson SM, De Camilli P, Flavell RA. Dynamin 2-dependent endocytosis sustains T-cell receptor signaling and drives metabolic reprogramming in T lymphocytes. Proc Natl Acad Sci USA 2015;112:4423-4428.
129. Yu MC, et al. An essential function for beta-arrestin 2 in the inhibitory signaling of natural killer cells. Nat Immunol 2008;9:898-907.
130. Treanor B, et al. Microclusters of inhibitory killer immunoglobulin-like receptor signaling at natural killer cell immunological synapses. J Cell Biol 2006;174:153-161.
131. Purdy AK, Alvarez Arias DA, Oshinsky J, James AM, Serebriiskii I, Campbell KS. The ap-2 clathrin adaptor mediates endocytosis of an inhibitory killer cell Ig-like receptor in human NK cells. J Immunol 2014;193:4675-4683.
132. Rao N, Dodge I, Band H. The Cbl family of ubiquitin ligases: critical negative regulators of tyrosine kinase signaling in the immune system. J Leukoc Biol 2002;71:753-763.
133. Martinez GJ, et al. The transcription factor NFAT promotes exhaustion of activated CD8(+) T cells. Immunity 2015;42:265-278.
134. Jenkins MR, et al. Failed CTL/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse time. J Exp Med 2015;212:307-317.
135. Dong Z, Cruz-Munoz ME, Zhong MC, Chen R, Latour S, Veillette A. Essential function for SAP family adaptors in the surveillance of hematopoietic cells by natural killer cells. Nat Immunol 2009;10:973-980.
136. Cui G, et al. Characterization of the IL-15 niche in primary and secondary lymphoid organs in vivo. Proc Natl Acad Sci USA 2014;111:1915-1920.
137. + T cells. Nat Immunol 2013;14:356-363.
138. Sharkey AM, et al. Killer Ig-like receptor expression in uterine NK cells is biased toward recognition of HLA-C and alters with gestational age. J Immunol 2008;181:39-46.
139. Bulmer JN, Longfellow M, Ritson A. Leukocytes and resident blood cells in endometrium. Ann N Y Acad Sci 1991;622:57-68.
140. Oppenheim DE, et al. Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance. Nat Immunol 2005;6:928-937.
141. Wiemann K, et al. Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo. J Immunol 2005;175:720-729.
142. Marcais A, et al. The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells. Nat Immunol 2014;15:749-757.